Pfizer looks to sell Midtown East HQ by the end of 2017

1M sf property on East 42nd Street is sticky subject in area’s rezoning

New York /
Oct.October 07, 2016 09:03 AM

Global pharmaceutical giant Pfizer is looking to sell its headquarters in Manhattan, a property that is becoming a contentious sticking point in the proposal to rezone Midtown East.

Pfizer told employees it plans to sell its aging buildings at 219 East 42nd Street and 235 East 42nd Street by the end of next year, the Wall Street Journal reported, and expects to lease a new headquarters somewhere in Manhattan.

The buildings are interconnected and have about 1 million square feet of space between them. It had previously mulled a redevelopment of the headquarters. The company thinks it would move no earlier than the first half of 2019.

“In order to bring our building up to modern standards, it is going to take a significant investment,” a Pfizer spokesperson said. “In terms of capital deployment, that is not where we want to focus.”

Company executives said that a “substantial majority” of those employees working in the current headquarters will stay in Manhattan, though some may be relocated to other locations throughout the tri-state area.

Pfizer expected to relocate its tax residence to Ireland earlier this year as part of its acquisition of the Dublin-based company Allergan, but that move was effectively quashed after the Obama administration made changes to tax laws.

The Pfizer property has a denser zoning than nearby parcels in Midtown East, and community advocates want to see the owner – whoever it may be – make more contributions to public improvements if the site is rezoned as part of the broader effort to modernize the business district. [WSJ]Rich Bockmann

 

Related Articles

arrow_forward_ios
43 East 53rd Street with ZG Capital Partners’ James Tamborlane and Bobby Zar (Google Maps, LinkedIn)
Bobby Zar buys Midtown office building for 15% less than 2015 price
Bobby Zar buys Midtown office building for 15% less than 2015 price
415 Madison Avenue and Rudin Management’s Bill Rudin (SOM, Rudin Management)
Rudin moves ahead with office building at 415 Madison Avenue
Rudin moves ahead with office building at 415 Madison Avenue
Silverback's Josh Schuster and Hopson's Chu Mang Yee with rendering of the project at 131-141 East 47th Street (LinkedIn, Getty, Ismael Leyva Architects)
Hopson nabs $156M for Midtown tower, agrees to part ways with Silverback
Hopson nabs $156M for Midtown tower, agrees to part ways with Silverback
Vanke US managing director Kai-yan Lee, RFR’s Aby Rosen and 100 East 53rd Street (Vanke US, Getty, M18 Public Relations)
With Aby Rosen out, Chinese developer slashes Midtown condo prices
With Aby Rosen out, Chinese developer slashes Midtown condo prices
Retail landlord Jack Terzi and 240 East 54th Street (Jack Terzi)
Terzi owes $58M and counting on Midtown SoulCycle building: suit
Terzi owes $58M and counting on Midtown SoulCycle building: suit
825 Third Avenue in Manhattan in NYC with Durst Organization financial associate Lucas Durst (LinkedIn, 825 Third Avenue)
Durst scores $100M loan for 825 Third
Durst scores $100M loan for 825 Third
ZG, Rialto buying former Santander building for $105M
ZG, Rialto buying former Santander building for $105M
ZG, Rialto buying former Santander building for $105M
Recruiter snags 71K sf at SL Green’s 711 Third Avenue
Recruiter snags 71K sf at SL Green’s 711 Third Avenue
Recruiter snags 71K sf at SL Green’s 711 Third Avenue
arrow_forward_ios

The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

Loading...